Demant A/S (DEMANT.CO)

DKK 225.8

(0.36%)

EBITDA Summary of Demant A/S

  • Demant A/S's latest annual EBITDA in 2023 was 5.21 Billion DKK , up 23.01% from previous year.
  • Demant A/S's latest quarterly EBITDA in 2024 Q2 was 1.17 Billion DKK , down 0.0% from previous quarter.
  • Demant A/S reported an annual EBITDA of 4.17 Billion DKK in 2022, down -3.15% from previous year.
  • Demant A/S reported an annual EBITDA of 4.46 Billion DKK in 2021, up 77.45% from previous year.
  • Demant A/S reported a quarterly EBITDA of 1.17 Billion DKK for 2024 Q2, down 0.0% from previous quarter.
  • Demant A/S reported a quarterly EBITDA of N/A for 2023 FY, up 23.01% from previous quarter.

Annual EBITDA Chart of Demant A/S (2023 - 2002)

Historical Annual EBITDA of Demant A/S (2023 - 2002)

Year EBITDA EBITDA Growth
2023 5.21 Billion DKK 23.01%
2022 4.17 Billion DKK -3.15%
2021 4.46 Billion DKK 77.45%
2020 2.4 Billion DKK -17.54%
2019 2.88 Billion DKK 4.16%
2018 2.74 Billion DKK 7.85%
2017 2.7 Billion DKK 17.19%
2016 2.27 Billion DKK 5.98%
2015 2.17 Billion DKK 7.36%
2014 1.93 Billion DKK -1.75%
2013 2 Billion DKK 9.28%
2012 1.88 Billion DKK 7.83%
2011 1.9 Billion DKK 22.32%
2010 1.46 Billion DKK 6.61%
2009 1.34 Billion DKK 25.16%
2008 1.21 Billion DKK -21.91%
2007 1.41 Billion DKK -4.43%
2006 1.43 Billion DKK 16.14%
2005 1.24 Billion DKK 8.46%
2004 1.13 Billion DKK 33.17%
2003 855.98 Million DKK 5.61%
2002 810.48 Million DKK 0.0%

Peer EBITDA Comparison of Demant A/S

Name EBITDA EBITDA Difference
Ambu A/S 691 Million DKK -655.137%
ChemoMetec A/S 193.97 Million DKK -2590.01%
GN Store Nord A/S 2.31 Billion DKK -125.594%
Scandinavian Medical Solutions A/S 21.22 Million DKK -24483.771%
ViroGates A/S -12.48 Million DKK 41907.547%